Utah Medical Products - 20 Year Stock Price History | UTMD

Historical daily share price chart and data for Utah Medical Products since 1999 adjusted for splits. The latest closing stock price for Utah Medical Products as of July 19, 2019 is 86.15.
  • The all-time high Utah Medical Products stock price is 115.30, which is 33.8% above the current share price.
  • The Utah Medical Products 52-week high stock price is 100.58, which is 16.7% above the current share price.
  • The Utah Medical Products 52-week low stock price is 74.64, which is 13.4% below the current share price.
  • The average Utah Medical Products stock price for the last 52 weeks is 87.69.
Utah Medical Products Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 86.1088 84.7700 99.2000 77.7600 86.1500 3.70%
2018 93.7483 78.3972 115.3033 74.6400 83.0800 3.24%
2017 68.3776 69.5329 83.0931 57.3110 80.4733 13.59%
2016 60.8573 56.2062 70.8476 53.1880 70.8476 26.31%
2015 53.6074 54.4561 59.2326 48.0506 56.0912 -0.72%
2014 49.3399 47.7972 56.5730 43.6797 56.4977 7.04%
2013 45.6233 34.6892 58.2887 34.6892 52.7838 61.74%
2012 29.0973 24.0157 32.7338 23.7255 32.6343 37.45%
2011 23.1225 22.9034 25.0860 21.1792 23.7431 4.07%
2010 22.2637 23.6455 24.8263 19.8901 22.8143 -2.73%
2009 20.4847 18.4902 23.8080 16.4619 23.4535 38.40%
2008 20.9530 22.0891 23.0593 16.3339 16.9461 -23.59%
2007 23.3352 23.9425 25.1839 21.7938 22.1787 -7.31%
2006 22.6023 21.6638 24.8749 20.1770 23.9280 5.78%
2005 16.5458 15.3164 22.6195 13.8613 22.6195 45.97%
2004 15.7167 17.3730 18.3499 11.7304 15.4957 -12.27%
2003 14.3080 13.0483 17.6636 11.8253 17.6636 36.86%
2002 10.5882 8.9196 13.0281 8.4736 12.9064 40.34%
2001 7.1091 5.0680 9.2845 4.7511 9.1967 81.47%
2000 4.8475 4.3517 5.6592 4.0544 5.0680 11.11%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.321B $0.042B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.348B 29.07
Medtronic (MDT) Ireland $135.189B 19.31
Stryker (SYK) United States $77.613B 27.70
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $42.395B 26.72
EssilorLuxottica Societe Anonyme (ESLOY) France $29.186B 0.00
Coloplast (CLPBY) Denmark $25.855B 41.28
Lonza Group Ag (LZAGY) Switzerland $25.565B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.282B 16.24
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $18.881B 0.00
ResMed (RMD) United States $17.703B 33.83
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.272B 0.00
Bio-Rad Laboratories (BIO) United States $9.392B 49.79
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.231B 526.83
Hill-Rom Holdings (HRC) United States $7.018B 21.27
Perrigo (PRGO) Ireland $7.012B 11.85
Aurora Cannabis (ACB) Canada $6.936B 68.40
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.251B 51.03
ICU Medical (ICUI) United States $5.188B 30.95
GW Pharmaceuticals (GWPH) United Kingdom $4.991B 0.00
Neogen (NEOG) United States $3.334B 54.21
NuVasive (NUVA) United States $3.016B 24.63
Hutchison China MediTech (HCM) China $2.777B 0.00
Agios Pharmaceuticals (AGIO) United States $2.746B 0.00
National Vision Holdings (EYE) United States $2.480B 52.83
Quidel (QDEL) United States $2.268B 23.54
Aphria (APHA) $1.604B 0.00
Cardiovascular Systems (CSII) United States $1.544B 886.40
Phibro Animal Health (PAHC) United States $1.216B 18.22
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.93
NanoString Technologies (NSTG) United States $1.114B 0.00
Lantheus Holdings (LNTH) United States $1.097B 29.13
PetIQ (PETQ) United States $1.015B 24.66
Quanterix (QTRX) United States $0.779B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.750B 21.03
Omeros (OMER) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.717B 0.00
TG Therapeutics (TGTX) United States $0.681B 0.00
LeMaitre Vascular (LMAT) United States $0.598B 28.97
OraSure Technologies (OSUR) United States $0.530B 24.40
Surmodics (SRDX) United States $0.527B 76.59
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.499B 0.00
Meridian Bioscience (VIVO) United States $0.492B 15.04
BioLife Solutions (BLFS) United States $0.330B 103.12
Vapotherm (VAPO) United States $0.320B 0.00
Zynex (ZYXI) United States $0.251B 25.77
Cytosorbents (CTSO) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
United-Guardian (UG) United States $0.092B 20.16
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 18.33